Publication | Closed Access

Sequential receptor–mediated mixed-charge nanomedicine to target pancreatic cancer, inducing immunogenic cell death and reshaping the tumor microenvironment

NanomedicineDrug TargetingNanotherapeuticsEngineeringPancreatic CancerTherapeutic NanomaterialsImmunologyTumor ImmunityDrug Delivery SystemsImmunotherapeuticsTumor TargetingBiomedical EngineeringMixed-charge NanomedicineMedicineRadiation OncologyTumor MicroenvironmentTumor Biology